Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu(Central South University), Rongrong Zhou(Central South University), Wentao Tian(Central South University), Jing Zhang(Sichuan Agricultural University), Ziqi Wang(Central South University)
Cited by 194
Related Papers
Cancer stem cells: advances in knowledge and implications for cancer therapy
|Signal Transduction and Targeted Therapy|2024|452
Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice
|Journal of Neuroinflammation|2018|299
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
|Frontiers in Cell and Developmental Biology|2021|78
The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
|Frontiers in Immunology|2022|55
Kaempferol induces apoptosis in HepG2 cells via activation of the endoplasmic reticulum stress pathway
|Molecular Medicine Reports|2016|54